Koers Guizhou Xinbang Pharmaceutical Co., Ltd.
Aandelen
002390
CNE100000NG5
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,69 CNY | -0,81% | -2,38% | -16,89% |
Omzet 2022 | 6,35 mld. 877 mln. 823 mln. | Omzet 2023 | 6,46 mld. 892 mln. 838 mln. | Marktkapitalisatie | 8,56 mld. 1,18 mld. 1,11 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 224 mln. 30,94 mln. 29,04 mln. | Nettowinst (verlies) 2023 | 287 mln. 39,64 mln. 37,21 mln. | EV/omzet 2022 | 1,52 x |
Nettoschuld 2022 | 493 mln. 68,15 mln. 63,97 mln. | Nettoschuld 2023 | 29,4 mln. 4,06 mln. 3,81 mln. | EV/omzet 2023 | 1,33 x |
K/w-verhouding 2022 |
39,2
x | K/w-verhouding 2023 |
29,6
x | Werknemers | 5.149 |
Dividendrendement 2022 |
1,28% | Dividendrendement 2023 |
1,35% | Vrij verhandelbaar | 50,7% |
1 dag | -0,81% | ||
1 week | -2,38% | ||
Lopende maand | -3,15% | ||
1 maand | -7,29% | ||
3 maanden | -9,56% | ||
6 maanden | -19,43% | ||
Lopend jaar | -16,89% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ling Zhong Kong
CEO | Chief Executive Officer | 56 | 01-01-00 |
Ya Yun Xiao
DFI | Director of Finance/CFO | 51 | 12-05-15 |
Chuan Chen
IRC | Investor Relations Contact | 55 | 25-03-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jin Hu
BRD | Director/Board Member | 48 | 11-02-17 |
Ling Zhong Kong
CEO | Chief Executive Officer | 56 | 01-01-00 |
Jie Qing Zhang
PRN | Corporate Officer/Principal | 49 | 17-02-12 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 3,69 | -0,81% | 13 969 970 |
18-04-24 | 3,72 | -0,53% | 15 902 910 |
17-04-24 | 3,74 | +3,60% | 22 360 420 |
16-04-24 | 3,61 | -2,70% | 26 065 780 |
15-04-24 | 3,71 | -1,85% | 20 761 450 |
slotkoers Shenzhen S.E., 19 april 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-16,89% | 980 mln. | |
+40,86% | 6,16 mld. | |
-16,30% | 4,49 mld. | |
-9,93% | 3,17 mld. | |
-1,58% | 3,01 mld. | |
-1,70% | 2,57 mld. | |
+37,23% | 1,8 mld. | |
-12,78% | 1,62 mld. | |
+1,02% | 1,56 mld. | |
-12,97% | 1,53 mld. |